Veracyte Inc.

Veracyte Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.42
Market Cap
$1.37 B
Shares Outstanding
47.97 M
Public Float
32.12 M

Profile

Address
6000 Shoreline Court
South San Francisco California 94080
United States
Employees -
Website http://www.veracyte.com
Updated 07/08/2019
Veracyte, Inc. engages in the research, development, and commercialization of diagnostic products. Its portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis.

Financials

View All
Created with Highcharts 5.0.14Veracyte Inc.Net Income. Fiscal year is January-December. All values USD Thousands.25 58025 58029 37329 37333 70433 70431 35831 35831 00331 00322 99922 999201320142015201620172018010k20k30k40k
Created with Highcharts 5.0.14Veracyte Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.21 88421 88438 19038 19049 50349 50365 08565 08571 95371 95392 00892 008201320142015201620172018025k50k75k100k

Bonnie H. Anderson
Chairman & Chief Executive Officer
Kevin K. Gordon
Independent Director